Trium Capital LLP
CIK: 0001963860
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MURA US
Mural Oncology plc
10% Owner
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
Trium Capital LLP files insider reports with the SEC as 10% Owner of Mural Oncology plc (MURA US).
About Trium Capital LLP
Trium Capital LLP (SEC CIK 0001963860) files insider reports with the SEC as 10% Owner of Mural Oncology plc (MURA US).
Signal8 holds 1 ownership filing by Trium Capital LLP, a Form 3, filed on Sep 2, 2025. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Trium Capital LLP's filings is in LONDON, X0.